We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
-2.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$25.2B
AUM Growth
+$145M
Cap. Flow
+$1.25B
Cap. Flow %
4.95%
Top 10 Hldgs %
11.42%
Holding
1,496
New
423
Increased
299
Reduced
316
Closed
358

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$278M
2
ADI icon
Analog Devices
ADI
+$181M
3
TGT icon
Target
TGT
+$172M
4
V icon
Visa
V
+$150M
5
AVGO icon
Broadcom
AVGO
+$148M

Sector Composition

Rank Sector Weight
1 Healthcare 23.22%
2 Technology 16.94%
3 Consumer Discretionary 10.54%
4 Industrials 7.2%
5 Energy 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1126
CALL
Annexon
ANNX
$860M
-146,000
Closed -$1.68M
ANNX icon
1127
Annexon
ANNX
$860M
-874,752
Closed -$10.1M
AON icon
1128
Aon
AON
$75.9B
-36,400
Closed -$10.9M
AR icon
1129
CALL
Antero Resources
AR
$11.2B
-400,000
Closed -$7M
ASND icon
1130
Ascendis Pharma A/S
ASND
$16B
-112,200
Closed -$15.1M
ASTL icon
1131
Algoma Steel
ASTL
$413M
-60,800
Closed -$657K
ATI icon
1132
ATI
ATI
$26.4B
-558,000
Closed -$8.89M
ATRO icon
1133
Astronics
ATRO
$3.51B
-21,600
Closed -$216K
AVA icon
1134
Avista
AVA
$3.31B
-22,000
Closed -$935K
AVB icon
1135
AvalonBay Communities
AVB
$27B
-4,800
Closed -$1.21M
AXON
1136
Axon Enterprise
AXON
$48.9B
-22,238
Closed -$3.49M
AXS icon
1137
AXIS Capital
AXS
$7.72B
-546,273
Closed -$29.8M
BASE
1138
DELISTED
Couchbase
BASE
-321,296
Closed -$8.02M
BAX icon
1139
Baxter International
BAX
$14.5B
-770,226
Closed -$66.1M
BB icon
1140
BlackBerry
BB
$5.2B
-52,100
Closed -$487K
BBIO icon
1141
CALL
BridgeBio Pharma
BBIO
$15.7B
-30,700
Closed -$512K
BBIO icon
1142
BridgeBio Pharma
BBIO
$15.7B
-50,312
Closed -$839K
BBIO icon
1143
PUT
BridgeBio Pharma
BBIO
$15.7B
-52,200
Closed -$871K
BBWI icon
1144
CALL
Bath & Body Works
BBWI
$4.24B
-50,000
Closed -$3.49M
BCRX icon
1145
BioCryst Pharmaceuticals
BCRX
$2.29B
-25,272
Closed -$350K
BEN icon
1146
Franklin Resources
BEN
$17.9B
-66,600
Closed -$2.23M
BGC icon
1147
BGC Group
BGC
$5.25B
-3,618,479
Closed -$16.8M
BIIB icon
1148
CALL
Biogen
BIIB
$29.8B
-10,000
Closed -$2.4M
BKH icon
1149
Black Hills Corp
BKH
$5.5B
-22,200
Closed -$1.57M
BMBL icon
1150
Bumble
BMBL
$417M
-275,257
Closed -$9.32M

Similar funds

Point72 Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Point72 Asset Management held 1,496 positions worth $25.2B, up 0.58% from $25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Point72 Asset Management deployed $1.25B of net new capital in Q1 2022, opening 423 new positions and adding to 299 existing holdings. Its largest new stake was Target: 794,997 shares worth $169M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Micron Technology, an estimated $168M trimmed.

  • Point72 Asset Management's largest Q1 2022 buy was Target: 794,997 shares worth $169M.
  • Point72 Asset Management added most to Merck in Q1 2022, an estimated $278M increase.
  • Point72 Asset Management's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $168M.
  • Point72 Asset Management fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $454M.
  • Point72 Asset Management's ten largest holdings make up 11% of its $25.2B portfolio in Q1 2022.
  • Point72 Asset Management opened 423 new positions and closed 358 in Q1 2022.
  • Point72 Asset Management's portfolio value rose 0.58% quarter-over-quarter to $25.2B.

Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.